These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37880317)

  • 1. New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo.
    Ocaña MC; Bernal M; Yang C; Caro C; Domínguez A; Vu HS; Cárdenas C; García-Martín ML; DeBerardinis RJ; Quesada AR; Martínez-Poveda B; Medina MÁ
    Commun Biol; 2023 Oct; 6(1):1084. PubMed ID: 37880317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases.
    Majkutewicz I
    Eur J Pharmacol; 2022 Jul; 926():175025. PubMed ID: 35569547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity.
    Liebmann M; Korn L; Janoschka C; Albrecht S; Lauks S; Herrmann AM; Schulte-Mecklenbeck A; Schwab N; Schneider-Hohendorf T; Eveslage M; Wildemann B; Luessi F; Schmidt S; Diebold M; Bittner S; Gross CC; Kovac S; Zipp F; Derfuss T; Kuhlmann T; König S; Meuth SG; Wiendl H; Klotz L
    Brain; 2021 Nov; 144(10):3126-3141. PubMed ID: 34849598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.
    Landeck L; Asadullah K; Amasuno A; Pau-Charles I; Mrowietz U
    Arch Dermatol Res; 2018 Aug; 310(6):475-483. PubMed ID: 29574575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro.
    Brennan MS; Matos MF; Li B; Hronowski X; Gao B; Juhasz P; Rhodes KJ; Scannevin RH
    PLoS One; 2015; 10(3):e0120254. PubMed ID: 25793262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity.
    Kornberg MD; Bhargava P; Kim PM; Putluri V; Snowman AM; Putluri N; Calabresi PA; Snyder SH
    Science; 2018 Apr; 360(6387):449-453. PubMed ID: 29599194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
    Linker RA; Gold R
    Curr Neurol Neurosci Rep; 2013 Nov; 13(11):394. PubMed ID: 24061646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
    Lim JL; van der Pol SM; Di Dio F; van Het Hof B; Kooij G; de Vries HE; van Horssen J
    Microvasc Res; 2016 May; 105():61-9. PubMed ID: 26679389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis.
    Venci JV; Gandhi MA
    Ann Pharmacother; 2013 Dec; 47(12):1697-702. PubMed ID: 24259625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diroximel fumarate to treat multiple sclerosis.
    Wang Y; Bhargava P
    Drugs Today (Barc); 2020 Jul; 56(7):431-437. PubMed ID: 32648853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
    Smith MD; Calabresi PA; Bhargava P
    Eur J Immunol; 2018 Feb; 48(2):380-383. PubMed ID: 29108094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice.
    Yao Y; Miao W; Liu Z; Han W; Shi K; Shen Y; Li H; Liu Q; Fu Y; Huang D; Shi FD
    Transl Stroke Res; 2016 Dec; 7(6):535-547. PubMed ID: 27614618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
    Haarmann A; Nehen M; Deiß A; Buttmann M
    Int J Mol Sci; 2015 Aug; 16(8):19086-95. PubMed ID: 26287168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antipsoriatic dimethyl-fumarate suppresses interferon-gamma -induced ICAM-1 and HLA-DR expression on hyperproliferative keratinocytes. Quantification by a culture plate-directed APAAP-ELISA technique.
    Sebok B; Bonnekoh B; Vetter R; Schneider I; Gollnick H; Mahrle G
    Eur J Dermatol; 1998; 8(1):29-32. PubMed ID: 9649687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorcaserin, dimethyl fumarate, and bedaquiline fumarate.
    Hussar DA; Polyak G
    J Am Pharm Assoc (2003); 2013; 53(3):328-30, 332, 334. PubMed ID: 23699683
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutually enhancing anti-inflammatory activities of dimethyl fumarate and NF-κB inhibitors--implications for dose-sparing combination therapies.
    Hund AC; Lockmann A; Schön MP
    Exp Dermatol; 2016 Feb; 25(2):124-30. PubMed ID: 26513635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl fumarate: a review of its use in patients with relapsing-remitting multiple sclerosis.
    Burness CB; Deeks ED
    CNS Drugs; 2014 Apr; 28(4):373-87. PubMed ID: 24623127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study.
    Højsgaard Chow H; Talbot J; Lundell H; Marstrand L; Gøbel Madsen C; Bach Søndergaard H; Bredahl Hansen M; Solberg Sørensen P; Siebner HR; Sellebjerg F
    Mult Scler Relat Disord; 2023 Feb; 70():104458. PubMed ID: 36586351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders.
    Manai F; Zanoletti L; Arfini D; Micco SG; Gjyzeli A; Comincini S; Amadio M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.
    Peng H; Li H; Sheehy A; Cullen P; Allaire N; Scannevin RH
    J Neuroimmunol; 2016 Oct; 299():35-44. PubMed ID: 27725119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.